All applications must address Cystic Fibrosis Canada’s Core Principles of funding the best science that has the highest probability of making an impact for CF patients. Research with strong alignment to one or more of the following will be funded:
Clinical Trials: Cystic Fibrosis Canada recognizes the importance of strong support for clinical trials of new drugs or treatments for cystic fibrosis. In most instances, particularly where new products are involved, funding will emanate from the manufacturer, as a normal component of the drug or product development process. In cases where such funding is not available or appropriate, the organization will entertain applications for limited support. In no instance will Cystic Fibrosis Canada provide financial support to trials which, by their nature, should be assumed by pharmaceutical companies or equipment manufacturers. For further information, see https://www.cysticfibrosis.ca/uploads/Cystic%20Fibrosis%20Canada%20Grants%20and%20Awards%20Guide%202023-2024.pdf#page=25
Travel: Research grants and early career investigator awards include a travel component. The organization encourages investigators to attend CF-related meetings in Canada or elsewhere, when advisable according to public health guidelines, to report on their own research and to remain abreast of significant developments in CF research. Presentation of a paper at a reputable scientific meeting, or attendance at a major symposium or conference related to the grantee's research are considered legitimate uses of travel funds.
Research grants may be allocated, in accordance with the approved budget, to:
For additional information on use of funds, see: https://www.cysticfibrosis.ca/uploads/Cystic%20Fibrosis%20Canada%20Grants%20and%20Awards%20Guide%202023-2024.pdf#page=34